(Q40386407)

20 September 2017

1 reference

title

Risperidone (English)

1 reference

20 September 2017

M G Livingston

1

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

343

1 reference

20 September 2017

issue

8895

1 reference

20 September 2017

page(s)

457-460

1 reference

The incidence of schizophrenia in Nottingham.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

Gender differences in tardive dyskinesia: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992696-4

7 January 2021

10.1016/S0140-6736(94)92696-4

Identifiers

DOI

1 reference

20 September 2017

1 reference